For research use only. Not for therapeutic Use.
KM02894(CAT: I040842) is a potent inhibitor of glutamate release, offering significant potential in cancer-related research. Cancer cells often secrete excessive glutamate, which disrupts normal bone turnover and contributes to cancer-induced bone pain. By reducing extracellular glutamate levels, KM02894 may help mitigate bone degradation and pain associated with tumor growth in the skeletal system. This compound is valuable for studying tumor-microenvironment interactions, bone metastases, and neuro-oncology. With its targeted mechanism, KM02894 serves as a promising research tool for exploring novel therapeutic strategies in oncology, bone disease, and pain management.
| CAS Number | 116850-74-9 |
| Synonyms | 1-methyl-3-(thiophene-2-carbonylamino)thiourea |
| Molecular Formula | C7H9N3OS2 |
| Purity | ≥95% |
| IUPAC Name | 1-methyl-3-(thiophene-2-carbonylamino)thiourea |
| InChI | InChI=1S/C7H9N3OS2/c1-8-7(12)10-9-6(11)5-3-2-4-13-5/h2-4H,1H3,(H,9,11)(H2,8,10,12) |
| InChIKey | SYXUJKFYUBHYNO-UHFFFAOYSA-N |
| SMILES | CNC(=S)NNC(=O)C1=CC=CS1 |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
